Clinical Trials

At Lehigh Valley Health Network, we are committed to providing our patients and community with the best possible care and treatments. Our research scientists are integrated with our clinical departments for a comprehensive, collaborative approach to research. Have a question about clinical trials? Contact the Network Office of Research and Innovation at 610-402-9543.

Showing 90 of 137 Clinical Trials

Clinical Research Trial

NRG-BR009 Breast Cancer

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal

Doctor(s) Running This Study
Maged F. Khalil, MD
Clinical Research Trial

URCC-21038 Observational

A Prospective Cohort Study of Cancer Survivors Treated with anti-PD-1/anti-PD-L1 Immunotherapy in a Community Oncology Setting

Doctor(s) Running This Study
Maged F. Khalil, MD
Clinical Research Trial

A012103 Breast Cancer

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

Doctor(s) Running This Study
Maged F. Khalil, MD
Clinical Research Trial

A012103 Breast Cancer

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

Doctor(s) Running This Study
Maged F. Khalil, MD
Clinical Research Trial

Zimmer Knee Study

Randomized Controlled Trial to Compare Persona OsseoTi Keel Cementless TKA vs Persona Keel Cemented TKA  A prospective, multi-center study to demonstrate safety, performance, and clinical benefits of the Persona Keel

Doctor(s) Running This Study
Harry W. Schmaltz, MD
Clinical Research Trial

EA9181

EA9181 A Phase III Randomized Trial of Steroids + Tyrosine Kinase Inhibitor (TKI) Induction with Chemotherapy or Blinatumomab for Newly Diagnosed BCR-ABL-positive Acute Lymphoblastic Leukemia (ALL) in Adults

Doctor(s) Running This Study
Maged F. Khalil, MD
Clinical Research Trial

EA9181

EA9181 A Phase III Randomized Trial of Steroids + Tyrosine Kinase Inhibitor (TKI) Induction with Chemotherapy or Blinatumomab for Newly Diagnosed BCR-ABL-positive Acute Lymphoblastic Leukemia (ALL) in Adults

Doctor(s) Running This Study
Maged F. Khalil, MD
Clinical Research Trial

Atrium

Abatacept for Immune Checkpoint Inhibitor associated Myocarditis: A Phase 3, Investigator-initiated, randomized, double-blind, placebo-controlled study to evaluate the Efficacy and safety of Abatacept compared to placebo in hospitalized participants with

Doctor(s) Running This Study
Deborah W. Sundlof, DO
Ranju Gupta, MD